Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$4.07
-1.9%
$4.95
$0.86
$6.08
$328.54M0.5120,734 shs71,888 shs
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$86.52
+0.2%
$88.73
$74.05
$91.16
$496.63M0.72126,620 shs347,614 shs
The RealReal, Inc. stock logo
REAL
RealReal
$3.40
-1.4%
$3.11
$1.00
$4.10
$365.52M2.991.81 million shs1.08 million shs
VGL
Vigil Health Solutions
C$0.67
+1.5%
C$0.67
C$0.36
C$0.79
C$12.15MN/A27,469 shs500 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
-1.93%-10.55%-20.82%-9.96%+266.67%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
+0.17%+1.94%-3.78%+1.92%+10.44%
The RealReal, Inc. stock logo
REAL
RealReal
-1.45%+7.94%-7.10%+68.32%+199.56%
VGL
Vigil Health Solutions
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioventus Inc. stock logo
BVS
Bioventus
3.0595 of 5 stars
3.50.00.00.00.64.21.9
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/AN/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
0.4445 of 5 stars
1.22.00.00.01.93.30.6
VGL
Vigil Health Solutions
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
3.00
Buy$7.6788.37% Upside
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
0.00
N/A$95.5710.46% Upside
The RealReal, Inc. stock logo
REAL
RealReal
2.33
Hold$3.616.30% Upside
VGL
Vigil Health Solutions
N/AN/AN/AN/A

Current Analyst Ratings

Latest RIB, VGL, REAL, PPH, and BVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
The RealReal, Inc. stock logo
REAL
RealReal
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$2.30 ➝ $3.70
3/13/2024
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $9.00
3/1/2024
The RealReal, Inc. stock logo
REAL
RealReal
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$512.34M0.63$0.78 per share5.25$2.80 per share1.45
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
$549.30M0.66N/AN/A($2.97) per share-1.14
VGL
Vigil Health Solutions
C$6.73M1.81C$0.22 per share2.99C$0.31 per share2.18

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23M-$2.52N/A10.18N/A-30.49%2.25%0.62%5/21/2024 (Estimated)
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/A20.57N/AN/AN/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
-$168.47M-$1.67N/AN/AN/A-30.67%N/A-26.38%5/7/2024 (Confirmed)
VGL
Vigil Health Solutions
N/AC$0.0513.96N/AN/AN/AN/AN/A

Latest RIB, VGL, REAL, PPH, and BVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
The RealReal, Inc. stock logo
REAL
RealReal
-$0.14N/A+$0.14N/AN/AN/A  
3/12/2024Q4 2023
Bioventus Inc. stock logo
BVS
Bioventus
$0.06$0.07+$0.01$0.24$124.84 million$135.42 million
2/29/2024Q4 2023
The RealReal, Inc. stock logo
REAL
RealReal
-$0.19-$0.15+$0.04-$0.09$142.80 million$143.37 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$1.561.80%N/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
N/AN/AN/AN/AN/A
VGL
Vigil Health Solutions
N/AN/AN/AN/AN/A

Latest RIB, VGL, REAL, PPH, and BVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/28/2024
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$0.53284/1/20244/2/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
1.66
1.53
1.01
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/A
The RealReal, Inc. stock logo
REAL
RealReal
N/A
1.25
1.13
VGL
Vigil Health Solutions
6.11
3.99
3.25

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/A
The RealReal, Inc. stock logo
REAL
RealReal
64.73%
VGL
Vigil Health Solutions
N/A

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
29.10%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/A
The RealReal, Inc. stock logo
REAL
RealReal
9.34%
VGL
Vigil Health Solutions
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
97079.17 million56.13 millionNot Optionable
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
147,0005.74 millionN/AOptionable
The RealReal, Inc. stock logo
REAL
RealReal
3,032105.95 million96.05 millionNot Optionable
VGL
Vigil Health Solutions
N/A18.13 millionN/ANot Optionable

RIB, VGL, REAL, PPH, and BVS Headlines

SourceHeadline
Jerriann VigilJerriann Vigil
health.usnews.com - July 22 at 1:30 AM
Pamela P. VigilPamela P. Vigil
health.usnews.com - July 20 at 5:48 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bioventus logo

Bioventus

NYSE:BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.
VanEck Pharmaceutical ETF logo

VanEck Pharmaceutical ETF

NASDAQ:PPH
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
RealReal logo

RealReal

NASDAQ:REAL
The RealReal, Inc. operates an online marketplace for resale luxury goods in the United State. The company offers various product categories, including women's fashion, men's fashion, jewelry, and watches. It primarily sells products through online marketplace and retail stores. The company was incorporated in 2011 and is headquartered in San Francisco, California.

Vigil Health Solutions

CVE:VGL
Vigil Health Solutions Inc. develops, markets, and distributes hardware and software solutions for care plans and monitoring the aged in Canada and the United States. The company offers the Vigil Integrated Care Management System, a non-invasive monitoring system for residents with dementia. It also offers vigil memory care systems; nurse call systems; vitality care systems; and cloud applications, as well as specialty monitoring and notification devices. The company serves customers, such as independent living, assisted living, skilled nursing facilities, and continuing care retirement communities or life plan communities. Vigil Health Solutions Inc. is headquartered in Victoria, Canada.